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COMPARISON	OF	PAIN	RELIEF	AND	FUNCTIONAL	IMPROVEMENT	
IN	LANDMARK	VS.	ULTRASOUND-GUIDED	CORTICOSTEROID		
INJECTIONS	FOR	ADHESIVE	CAPSULITIS:	A	PROSPECTIVE	STUDY	
	
	
RYAN	P.	COENE		ABSTRACT	
Background:	Adhesive	capsulitis	is	an	idiopathic	disorder	of	the	shoulder	that	is	characterized	by	pain	in	combination	with	the	gradual	loss	of	passive	and	active	range	of	motion.	It	is	typically	self-limiting,	although	the	disease	still	remains	poorly	understood.	However,	there	are	several	treatment	modalities,	both	conservative	and	surgical,	that	provide	significant	clinical	benefit	for	patients	with	adhesive	capsulitis.	Corticosteroid	injections	are	an	established	conservative	treatment	method	for	adhesive	capsulitis.	Several	studies	have	demonstrated	that	injections	provide	short-term	benefits	in	terms	of	shoulder	mobility	and	pain	reduction.	The	intra-articular	injections	can	be	performed	blindly	(landmark)	or	with	ultrasound	(US)	guidance.	Physicians	administer	injections	under	US	guidance	in	an	attempt	to	improve	the	accuracy	of	the	injection.	However,	it	remains	unclear	whether	US-guided	injections	relieve	symptoms	of	adhesive	capsulitis	more	effectively	than	landmark	injections.			
Objective:	To	compare	the	pain	relief,	self-reported	function,	and	shoulder	range	of	motion	(ROM)	outcomes	of	landmark	versus	US-guided	corticosteroid	injections	for	adhesive	capsulitis.		
		 vi 
Methods:	A	total	of	21	patients	with	adhesive	capsulitis	were	randomized	to	receive	either	a	landmark	or	US-guided	intra-articular	corticosteroid	injection.	Clinical	outcome	measures	were	documented	at	baseline,	6	weeks,	and	12	weeks.	These	measures	included	a	visual	analog	scale	(VAS)	for	pain,	the	Single	Assessment	Numeric	Evaluation	(SANE)	score	for	self-reported	function,	and	passive	shoulder	ROM,	including	forward	flexion,	external	rotation,	and	abduction.	
Results:	Both	US-guided	and	landmark	glenohumeral	(GH)	joint	injections	significantly	improved	VAS	scores,	SANE	scores,	and	shoulder	ROM	outcomes.	Improvement	was	maintained	for	all	outcome	measures	in	both	groups	throughout	the	12	week	treatment	period.	However,	there	were	no	significant	differences	seen	in	outcome	measures	between	the	two	groups	except	that	US-guided	provided	greater	improvement	in	abduction	at	the	6	week	follow-up	(P	=	.004).	
Conclusions:	This	preliminary	report	found	that	there	is	no	significant	difference	in	the	effectiveness	of	US-guided	and	landmark	cortisone	injection	in	terms	of	pain	improvement,	self-reported	functions,	and	ROM	outcomes	for	adhesive	capsulitis.		
		 		 	
		 vii 
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INTRODUCTION	Adhesive	capsulitis	is	a	debilitating	shoulder	condition	that	causes	significant	morbidity	and	limitation.	It	is	marked	by	the	following	characteristics:	pain,	stiffness,	and	gradual	loss	of	active	and	passive	shoulder	ROM.	Also	referred	to	as	frozen	shoulder	or	periarthritis,	adhesive	capsulitis	occurs	in	about	3%	of	the	general	population	(Ewald,	2011).	Earnest	Codman,	a	physician,	first	coined	the	term	“frozen	shoulder”	in	1934	as	the	result	of	patients	with	the	condition	sharing	common	features:	a	gradual	onset	of	pain,	inability	to	sleep	on	the	affected	shoulder,	limited	external	rotation,	and	normal	radiographs	(Bunker	1997).	Reflected	in	the	multitude	of	names	for	this	condition,	literature	on	adhesive	capsulitis	is	conflicting	regarding	etiology,	natural	history,	and	effective	treatment	methods.	Though	the	etiology	of	adhesive	capsulitis	remains	unclear,	it	is	clinically	defined	as	a	restriction	in	shoulder	ROM	in	the	absence	of	any	significant	GH	joint	changes.			
Diagnosis/Clinical Phases Though	there	is	no	“gold	standard,”	diagnosis	of	frozen	shoulder	is	based	upon	physical	examination,	exclusion	of	other	shoulder	conditions,	and	absence	of	radiographic	GH	joint	abnormalities	(Lewis	2015).	Clinical	exam	is	marked	by	the	loss	of	active	and	passive	range	of	motion,	in	which	pain	can	be	exacerbated	as	the	capsule	reaches	its	stretching	point.	An	early	onset	of	adhesive	capsulitis	often	appears	analogous	to	other	common	shoulder	disorders	such	as	impingement	syndrome,	rotator	cuff	(RTC)	tears,	or	trauma	(Manske	2008).	A	patient’s	surgical	
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history	must	also	be	considered	as	a	surgical	procedure	of	the	shoulder	can	elicit	post-operative	stiffness.	Radiographs	of	the	shoulder	are	essential	as	they	can	rule	out	GH	osteoarthritis	or	chronic	anterior/posterior	dislocations	that	can	also	elicit	pain	and	restricted	shoulder	ROM.		Adhesive	capsulitis	is	classically	regarded	as	a	three-stage	disease	categorized	by	freezing,	frozen,	and	thawing	stages.	The	first	stage	is	characterized	by	the	development	of	substantial	pain	in	the	shoulder.	In	the	next	phase,	the	“frozen”	stage,	patients	typically	report	stiffness	and	loss	of	range	of	motion	in	the	shoulder.	Finally,	the	“thawing”	stage	is	relatively	painless,	marked	by	progressive	improvement	in	shoulder	range	of	motion,	and	can	last	from	9-18	months	(Nagy	2013).	The	natural	history	of	adhesive	capsulitis	remains	nebulous	but	it	is	generally	believed	that	resolution	occurs	between	two	to	three	years	(Xiao	2016).	However,	there	have	been	multiple	studies	that	have	shown	a	more	variable	prognosis,	in	which	pain	and	limitation	of	the	condition	have	persisted	over	7	years	(Hand	2008,	Vastamäki	2012).				
Classification	Adhesive	capsulitis	is	typically	classified	into	two	categories:	primary	or	secondary.	Primary	frozen	shoulder	is	idiopathic	and	lacks	radiographic	evidence	of	GH	osteoarthritis,	calcific	tendinitis,	and	partial	or	full-thickness	RTC	tears	(Xiao	2016).	It	is	also	characterized	by	global	capsular	inflammation	and	fibrosis	in	the	GH	joint	without	any	known	participating	cause	(D’Orsi	2012).		
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Secondary	adhesive	capsulitis	develops	as	the	result	of	an	underlying	medical	condition,	most	commonly	diabetes	and	thyroid	disorders	(Neviaser	2010,	Nagy	2013).	A	study	by	Tighe	and	Oakley	(2008)	involving	88	patients	with	adhesive	capsulitis	and	no	known	history	of	diabetes	mellitus	demonstrated	that	38.6%	(34	patients)	had	diabetes	and	32.95%	(29	patients)	had	prediabietes.	A	total	prevalence	of	71.5%	(63	of	88	patients)	had	a	diabetic	condition.	Frozen	shoulder	can	also	develop	from	immobilization	secondary	to	trauma	or	upper	extremity	surgery.	Additionally,	other	medical	disorders	such	as	Parkinson’s	disease,	cardiac	disease,	and	pulmonary	disease	have	been	associated	with	adhesive	capsulitis	(Nagy	2013).		
	
Treatment/Management	Although	this	condition	is	viewed	as	a	self-limiting	disease,	pain	and	limitation	has	been	reported	to	last	up	to	several	years.	Given	the	variability	in	the	natural	history	of	frozen	shoulder	several	treatment	methods	are	utilized	for	therapeutic	purposes	and	to	potentially	shorten	the	course	of	this	disease.	Standard	conservative	treatments	for	adhesive	capsulitis	include	supervised	neglect,	NSAIDs,	oral	corticosteroids,	physical	therapy	(PT),	corticosteroid	injection,	hydraulic	distension,	and	sodium	hyaluronate	injections.	Surgical	intervention,	typically	considered	after	conservative	treatments	have	been	exhausted,	includes	manipulation	under	anesthesia	(MUA)	and	arthroscopic	capsular	release.		
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A	systematic	review	by	Levine	et	al	(2007)	demonstrated	that	approximately	90%	of	patients	are	treated	effectively	through	conservative	treatment	methods,	such	as	a	physical	therapy	regimen	supplemented	with	NSAIDs	or	intra-articular	cortisone	injections.	Those	that	did	undergo	surgical	treatment	initially	received	an	average	of	12.2	months	of	non-operative	management	prior	to	requiring	surgery.	A	prospective	study	by	Griggs	(2000),	demonstrated	that	a	majority	of	patients	with	adhesive	capsulitis	could	be	successfully	treated	with	multi-directional	shoulder-stretching	exercises.	This	study	also	concluded	that	surgical	intervention	is	rarely	required,	and	that	the	early	use	of	operative	treatment	for	frozen	shoulder	needs	further	investigation.	Despite	the	ubiquity	of	this	condition	and	the	advances	made	in	shoulder	surgery,	it	is	still	difficult	for	physicians	to	choose	the	most	efficient	option	to	treat	this	issue	(Uppal	2015).			
NSAIDs		NSAIDs	are	one	of	the	most	common	medicines	used	for	pain	relief	worldwide.	They	act	as	an	analgesic	and	anti-inflammatory	agent	through	inhibiting	the	synthesis	of	prostaglandins,	which	promote	pain	and	inflammation.	NSAIDs	are	used	to	treat	a	variety	of	musculoskeletal	disorders	and	are	often	prescribed	to	supplement	other	modalities,	such	as	physical	therapy	or	corticosteroid	injections.	Unfortunately,	there	have	been	no	studies	conducted	that	evaluate	the	effectiveness	of	NSAIDs	alone	for	adhesive	capsulitis.		
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Rhind	et	al	(1982)	conducted	a	double-blind	study	comparing	the	efficacies	of	naproxen	and	indomethacin	in	the	treatment	of	adhesive	capsulitis.	Results	demonstrated	significant	reductions	in	pain	compared	to	baseline	over	a	course	of	four	weeks.	However,	this	trial	did	not	compare	NSAIDs	to	placebo	or	supervised	neglect.	Thus,	pain	reduction	could	have	resulted	from	the	natural	disease	course	despite	the	use	of	NSAIDs.		A	recent	randomized	control	trial	by	Ranalletta	et	al	(2016)	assessed	the	pain	relief	and	recovery	of	function	in	74	patients	from	a	single	intra-articular	corticosteroid	injection	prior	to	PT	compared	to	the	use	of	NSAIDs	and	PT.	Clinical	outcomes	were	documented	at	the	2,	4,	8,	and	12	weeks	and	were	based	on	a	variety	of	scales	and	scores.	Results	demonstrated	that	functional	outcomes	improved	significantly	with	each	treatment	group	at	all	time	points	and	that	the	American	Shoulder	and	Elbow	Surgeons	(ASES)	shoulder	scores	were	significantly	higher	in	the	intervention	group	in	all	the	weeks	except	for	week	12	(Figure	1).	They	were	able	to	conclude	that	a	single	intra-articular	cortisone	injection	prior	to	physical	therapy	accelerated	pain	reduction	and	rehabilitation	compared	to	treatment	with	NSAIDs	and	PT.					 	
	
	
	
	
	6 
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
Figure	1.	Changes	in	function	outcomes	assessed	by	American	Shoulder	and		 	
Elbow	Surgeons	(ASES)	Shoulder	Score	over	time	in	the	intervention	and	
control	groups.	Figure	taken	from	(Ranalletta	2016).	
	 There	are	adverse	effects	associated	with	the	use	of	NSAIDs.	Prolonged	use	of	NSAIDS	can	lead	to	an	increased	risk	of	developing	a	cardiovascular,	renal,	or	gastrointestinal	problem	(Sostres	2010).	The	potential	adverse	effects	from	long-term	use	and	scarcity	of	studies	on	NSAIDs	used	alone	for	adhesive	capsulitis	demonstrates	ambiguity	regarding	the	utilization	of	NSAIDs	for	effective	treatment	of	frozen	shoulder.		
Oral	Corticosteroids	Corticosteroids	are	involved	in	several	physiological	processes,	including	stress	response,	inflammation	regulation,	carbohydrate	metabolism,	and	immune	function.	Oral	corticosteroids	reduce	pain	and	inflammation	by	inhibiting	several	pathways	of	inflammation.	A	prospective	study	comparing	the	efficacies	of	oral	
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corticosteroids	and	intra-articular	cortisone	injections	demonstrated	similar	pain	reduction	in	both	groups,	yet	lower	restoration	of	shoulder	mobility	and	patient	satisfaction	in	the	group	receiving	oral	corticosteroid	treatment	(Lorbach	2010).	A	study	by	Walters	(2007)	found	that	oral	corticosteroids	provided	significant	pain	relief	and	increased	shoulder	mobility	in	the	short-term	(3-6	weeks),	but	provided	no	significant	benefit	after	six	weeks	when	compared	with	placebo	or	no	treatment.		A	Cochrane	review	by	Buchbinder	et	al	(2006)	examined	multiple	randomized	control	trials	that	investigated	the	role	of	oral	corticosteroids	compared	to	placebo,	no	treatment,	and	intra-articular	cortisone	injections.	This	review	was	unable	to	draw	conclusions	on	the	efficacy	of	oral	steroids	for	treatment	of	adhesive	capsulitis,	although	results	suggested	they	provided	short-term	benefits	(Table	1).		Adverse	effects	associated	with	use	of	oral	corticosteroids	include	increased	blood	glucose	levels	in	diabetic	and	non-diabetic	patients.	A	hyperglycemic	response	to	oral	corticosteroids	can	result	in	difficulties	managing	blood	glucose	levels	in	diabetic	patients.	
Table	1.	Key	Review	Results	(Buchbinder	2006).	Table	taken	from	(Griggs	2000).		
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Physical	Therapy	Physical	therapy	supplemented	with	a	home	exercise	regimen	is	the	mainstay	of	treatment	for	adhesive	capsulitis,	regardless	of	the	stage	of	disease	(Diercks	2004).	It	is	thought	that	PT	reduces	the	contraction	of	the	shoulder	musculature	and	ligaments	as	well	as	improves	pain	and	mobility	through	facilitating	the	interaction	between	the	synovial	fluid	and	cartilage	matrix	(Page	2014).		Although	PT	is	typically	the	first	treatment	advised	to	prevent	further	reduction	of	range	of	motion,	there	is	minimal	research	that	supports	the	use	of	therapy.	Additionally,	the	heterogeneity	of	PT	protocols	and	adherence	to	these	protocols	makes	it	difficult	to	assess	the	effectiveness	of	PT	in	treatment	of	adhesive	capsulitis	(Xiao	2016).			A	study	by	Diercks	et	al	(2004)	compared	supervised	neglect	(supportive	therapy	and	exercises	within	pain	limits)	and	intensive	PT	(passive	stretching	and	manual	mobilization).	It	was	found	that	patients	who	engaged	in	supervised	neglect	had	significantly	better	clinical	outcomes	than	those	who	were	enrolled	in	intense	PT.	These	results	demonstrate	that	level	of	intensity	and	adherence	to	PT	may	play	a	role	in	its	effectiveness.	A	recent	randomized	controlled	trial	evaluated	the	effectiveness	of	a	static	progressive	stretch	device	as	an	adjunct	to	PT	(Ibrahim	2014).	Results	showed	that	the	device	in	combination	with	PT	was	beneficial	in	long-term	pain	and	shoulder	ROM	improvements.	At	a	12	month	follow-up,	the	group	using	the	device	and	receiving	PT	continued	to	progress,	while	those	in	the	group	receiving	therapy	alone	had	regressed.	
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There	have	been	multiple	studies	that	have	compared	the	efficacies	of	corticosteroid	injections	versus	physical	therapy.	Studies	by	van	der	Windt	et	al	(1998)	and	Blanchard	(2010)	found	that	cortisone	injections	are	significantly	more	effective	in	restoring	shoulder	mobility	and	improving	pain	than	physical	therapy.		Two	studies	have	found	that	combining	a	corticosteroid	injection	with	PT	is	more	beneficial	than	an	injection	or	PT	alone,	in	terms	of	both	pain	and	mobility	(Carette	2003,	Ryans	2005).	This	was	further	supported	in	a	meta-analysis	by	Maund	et	al	(2012),	which	found	that	the	injection	and	PT	combination	provides	significant	pain	reduction	compared	to	either	modality	alone.	Thus	far,	it	appears	that	a	combined	treatment	approach	of	a	corticosteroid	injection	followed	by	a	course	of	physical	therapy	results	in	the	greatest	improvement	in	pain	and	should	mobility.	
	
Surgical	Intervention	Surgical	treatment	for	adhesive	capsulitis	is	typically	considered	in	patients	with	refractory	pain	and	limited	shoulder	range	of	motion	after	conservative	measures	have	been	exhausted.	The	procedures	that	are	most	often	utilized	are	MUA	and	arthroscopic	capsular	release.		During	MUA,	a	general	anesthetic	is	administered	and	the	joint	capsule	of	the	affected	shoulder	is	gently	stretched.	A	prospective	study	conducted	by	Jacobs	(2009)	compared	MUA	and	intra-articular	steroid	injection	for	adhesive	capsulitis.	They	found	that	steroid	injections	were	less	invasive	than	MUA,	which	has	multiple	potential	setbacks,	including	cost,	hospital	admission,	subjection	to	general	
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anesthesia,	and	potential	for	shoulder	injury.	Uitvlugt	et	al	(1993)	reported	on	arthroscopic	findings	within	the	shoulder	before	and	after	MUA	in	twenty	patients	with	adhesive	capsulitis.	Findings	demonstrated	a	joint	capsule	that	was	challenging	to	infiltrate	due	to	increased	thickness	of	capsular	tissue,	diminished	amount	of	intra-synovial	fluid,	and	reduction	of	joint	space	between	the	humeral	head	and	glenoid	fossa.	Arthroscopic	findings	following	the	manipulation	showed	synovial	and	capsular	hemorrhage,	increased	fluid	acceptance,	and	a	humerus	that	was	easily	distracted	away	from	the	glenoid.		A	study	by	Berghs	(2004)	examined	the	results	of	arthroscopic	capsular	release	in	25	patients	with	primary	adhesive	capsulitis.	These	patients	averaged	13.6	months	from	time	of	onset	of	the	condition	to	undergoing	the	procedure,	which	was	indicated	due	to	extreme	disability	or	unresponsiveness	to	conservative	measures.	Results	demonstrated	that	36%	had	dramatic	improvement	in	terms	of	pain	relief	and	functional	gain	on	the	first	post-operative	day,	and	88%	did	within	the	first	two	weeks.	This	study	concluded	that	arthroscopic	release	is	an	effective	treatment	for	adhesive	capsulitis,	with	rapid	pain	relief	and	improvement	in	shoulder	function	in	a	majority	of	patients.	Another	study	observing	the	results	of	arthroscopic	capsular	release	found	similar	results	and	concluded	that	the	procedure	is	a	safe	and	effective	treatment	for	adhesive	capsulitis	(Segmüller 1995). 	A	recent	systematic	review	compared	these	two	surgical	procedures	and	found	that	both	MUA	and	arthroscopic	capsular	release	provide	improvement	in	pain,	shoulder	range	of	motion,	and	patient-reported	outcomes	in	patients	who	
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continued	to	be	limited	by	adhesive	capsulitis	despite	undergoing	non-surgical	treatment	(Grant	2013).	It	was	also	suggested	that	future	studies	should	evaluate	if	the	two	procedures	are	indicated	in	the	same	or	different	patient	populations	as	well	as	evaluate	the	combined	use	of	MUA	and	arthroscopic	capsular	release.	A	relatively	recent	study	that	concurrently	evaluated	non-operative	and	operative	treatment	for	adhesive	capsulitis	found	that	patients	who	are	refractory	to	conservative	measures	respond	well	to	surgical	treatment,	either	manipulation	and	arthroscopic	release	(Rill	2011). While	it	is	evident	that	both	manipulation	and	arthroscopic	capsular	release	are	effective	surgical	measures	for	adhesive	capsulitis,	they	should	only	be	considered	for	patients	unresponsive	to	conservative	measures.	
	
Hyaluronate	Injections																	Hyaluronate	is	a	glycosaminoglycan	present	in	multiple	tissues	throughout	the	body.	Hyaluronans	play	an	integral	role	in	the	structure	and	function	of	articular	cartilage	(Blaine	2008).	Hyaluronate	has	viscous	and	lubricating	properties,	which	can	be	attributed	to	its	anionic	nature	that	attracts	water.	It	has	been	posited	to	be	an	applicable	treatment	for	adhesive	capsulitis	acting	through	suppression	of	inflammatory	elements	of	the	cartilage	matrix	and	lubrication	of	inflamed	joints	(Gross	2013).	The	rationale	of	utilizing	hyaluronate	injections	was	that	they	could	be	as	effective	as	corticosteroids,	yet	without	the	possible	side	effects	that	can	accompany	a	cortisone	injection.		
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																		However,	evidence	to	support	the	utilization	of	hyaluronate	injections	for	adhesive	capsulitis	has	been	inadequate.	A	study	by	Lim	et	al	(2014)	demonstrated	that	there	were	no	significant	differences	between	hyaluronate	and	corticosteroids	in	terms	of	improvement	of	pain	and	shoulder	mobility.	Another	study	compared	PT	against	hyaluronate	injection	combined	with	PT	for	adhesive	capsulitis	(Hsieh	2012).	While	results	demonstrated	that	both	treatments	provided	improvement,	there	was	no	significant	benefit	reported	with	the	addition	of	a	hyaluronate	injection	with	PT.	A	review	by	Lee	et	al	(2015)	found	similar	results	in	that	hyaluronate	injections	were	not	superior	to	established	conservative	treatments	for	adhesive	capsulitis,	and	that	addition	of	a	hyaluronate	injection	to	a	conventional	therapy	provides	no	significant	benefit.	Conversely,	a	systematic	review	by	Harris	et	al	(2011)	established	that	hyaluronate	injections	provided	short-term	improvement	in	shoulder	ROM	and	pain	compared	to	control.	This	review	went	on	to	further	conclude	that	hyaluronate	injections	are	effective	alternatives	to	cortisone	injections	in	the	management	for	adhesive	capsulitis.																The	most	common	adverse	reaction	to	hyaluronate	injections	is	pain	and	swelling	at	the	injection	site.	Additionally,	rare	incidences	of	pseudogout	and	severe	acute	inflammatory	reaction	have	been	reported	to	be	associated	with	hyaluronate	injections	(Hammesfahr	2003).	
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Corticosteroid	Injections	Cortisone	injections	are	one	of	the	most	commonly	utilized	treatment	methods	by	physicians	for	adhesive	capsulitis.	However,	it	is	still	uncertain	whether	corticosteroid	injections	have	an	actual	impact	on	shortening	the	disease	course	of	frozen	shoulder	(Bulgen	1984).	These	injections	act	within	the	shoulder	through	reduction	of	synovial	and	GH	joint	inflammation	(Gross	2013).	Additionally,	a	study	by	Hettrich	et	al	(2016)	demonstrated	that	intra-articular	corticosteroid	injections	for	adhesive	capsulitis	decreases	the	number	of	fibroblasts,	presence	of	fibromatosis,	and	vascular	hyperplasia,	thus	altering	the	disease	course	through	reduction	in	pathologic	changes	within	the	capsular	tissue.		Several	studies	have	established	that	corticosteroid	injections	provide	short-term	benefits	(from	6-16	weeks)	in	terms	of	pain	improvement	and	restoration	of	shoulder	ROM	(Carette	2003,	Ryans	2005,	Ucuncu	2009,	Hong	2011,	Roh	2012,	Song	2014,	Ranalletta	2016).	Additionally,	a	study	by	van	der	Windt	et	al	(1998)	demonstrated	that	multiple	corticosteroid	injections	(up	to	three)	were	superior	to	PT	in	improvement	of	pain	and	shoulder	function	for	adhesive	capsulitis.	A	review	by	Shah	et	al	(2011)	found	evidence	that	up	to	three	injections	in	a	sixteen	week	period	were	beneficial	in	treating	adhesive	capsulitis.	There	was	limited	evidence	supporting	four	to	six	injections	and	no	evidence	found	supporting	more	than	6	injections.	Despite	the	abundant	evidence	for	short-term	benefits	of	corticosteroid	injections,	it	is	still	unclear	whether	these	injections	provide	long-term	improvement	or	change	the	disease	course	of	adhesive	capsulitis.		
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While	localized	corticosteroid	injections	are	thought	to	limit	systemic	effects	compared	to	oral	administration,	effects	such	as	increased	blood	glucose	levels	have	been	reported	in	diabetic	patients.	However,	a	prospective	study	by	Habib	et	al	(2007)	examining	the	effects	of	intra-articular	corticosteroid	injections	at	the	shoulder	in	diabetic	patients	found	that	the	injections	have	no	significant	effects	on	blood	glucose	levels.		The	most	common	adverse	reaction	is	localized	pain	and	permanent	skin	depigmentation	at	the	site	of	the	injection	(Gaujoux-Viala	2009).	Other	side	effects	from	receiving	a	corticosteroid	injection	include	injection	flare,	arthroscopic	flare,	and	increased	tendon	damage	(Lim	2014).	Additionally,	a	recent	report	by	Maviki	et	al	(2013)	found	that	two	HIV-positive	patients	on	antiretrovirals	developed	symptoms	of	iatrogenic	Cushing’s	syndrome	following	administration	of	a	corticosteroid	injection.			
Dosage	There	have	been	multiple	studies	that	have	investigated	the	optimal	dose	of	corticosteroid	in	injections	for	adhesive	capsulitis.		A	randomized,	double-blind	trial	by	de	Jong	et	al	(1998)	demonstrated	that	an	intra-articular	dose	of	40	mg	of	corticosteroid	provided	greater	relief	than	a	dose	of	10	mg.	However,	two	other	studies	have	found	that	a	higher	dose	(40	mg)	was	not	more	efficacious	in	terms	of	improving	pain	or	shoulder	function	than	a	lower	dose	(20	mg)	(Hong	2011,	Yoon	2013).	Given	these	contradictory	findings,	the	optimal	dose	of	intra-articular	corticosteroids	for	frozen	shoulder	remains	unclear.	Future	research	to	further	
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investigate	the	optimal	dose	is	indicated	given	the	potential	adverse	effects	of	corticosteroid	treatment.			
Subacromial	vs.	Glenohumeral	Typically,	physicians	have	preferred	to	administer	an	intra-articular	GH	joint	cortisone	injection	for	adhesive	capsulitis.	However,	there	are	a	multitude	of	studies	that	compare	the	efficacies	of	the	GH	joint	and	subacromial	approach.	Two	studies	have	found	that	subacromial	and	GH	approaches	have	equal	efficacy	in	improving	pain	and	shoulder	function	(Rizk	1991,	Oh	2011).	Another	study	showed	that	both	GH	joint	and	subacromial	injections	are	more	effective	in	improving	pain	and	shoulder	function	than	NSAIDs,	while	there	was	no	significant	difference	seen	in	outcomes	between	the	two	injection	approaches	(Shin	2013).	A	study	by	Kim	(2015)	determined	that	a	subacromial	lidocaine	injection	prior	to	a	corticosteroid	injection,	regardless	of	location	in	the	shoulder,	is	more	effective	in	pain	improvement	than	the	conventional	GH	joint	injection.	Despite	the	limited	studies	comparing	the	two	injections	sites,	current	research	has	demonstrated	that	the	two	approaches	are	nearly	equal	in	efficacy	in	pain	improvement	and	restoration	of	shoulder	mobility	for	adhesive	capsulitis.		
Landmark	vs.	Image-Guided				 Many	physicians	have	begun	utilizing	US-guidance	for	intra-articular	corticosteroid	injections	in	an	attempt	to	improve	accuracy.	A	few	studies	that	have	
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examined	the	accuracy	of	landmark	GH	joint	injections	have	found	a	wide	range	in	accuracy,	varying	from	45-98%	(Jo	2011,	Johnson	2011,	Tobola	2011,	Sidon	2013).	The	study	conducted	by	Tobola	et	al	(2011)	compared	the	accuracy	of	three	different	approaches	for	GH	joint	injections	as	well	as	the	experience	of	the	provider.	While	there	were	no	significant	differences	found	between	the	three	approaches,	the	anterior	was	superior	in	accuracy,	independent	of	the	experience	level	of	the	physician.	Two	systematic	reviews	observing	the	accuracy	of	US-guided	GH	joint	injections	also	demonstrated	a	wide	range	of	accuracy,	from	63-100%	(Amber	2014,	Aly	2015).	The	review	by	Amber	et	al	(2014)	compared	the	accuracy	of	US-guided	and	fluoroscopy-guided	GH	joint	injections.	Results	indicated	that	US	was	superior	in	accuracy	compared	to	fluoroscopy,	albeit	not	to	a	statistically	significant	level.	Additionally,	because	fluoroscopy	exposes	both	the	patient	and	physician	to	radiation,	US	may	be	the	preferred	technique	for	image-guided	GH	joint	injections.			There	is	a	paucity	of	studies	that	have	directly	compared	the	two	injection	techniques.	A	study	by	Lee	et	al	(2009)	found	that	US-guided	injections	delivered	greater	reduction	in	pain	and	increased	shoulder	ROM	two	weeks	subsequent	to	the	injection,	after	which	time	no	significant	difference	was	observed	between	the	two	groups.	However,	this	study	failed	to	examine	the	effects	of	the	injections	alone	as	they	were	followed	by	hyaluronate	injections.	A	second	study	found	that	the	US-guided	injections	delivered	better	ROM	and	pain	outcomes	than	landmark	injections	
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at	6	weeks	post-injection	(Ucuncu	2009).	Yet,	this	study	evaluated	other	shoulder	disorders	like	RTC	impingement	syndrome	in	addition	to	adhesive	capsulitis.		A	Cochrane	review	compared	US-guided	and	blind	cortisone	injections	for	shoulder	pain	and	found	no	significant	differences	in	pain	or	shoulder	ROM	(Bloom	2012).	The	review	concluded	that	while	US-guidance	may	improve	accuracy	of	the	injection,	it	is	still	unclear	if	this	improves	its	efficacy	to	warrant	the	significantly	increased	cost	of	the	procedure.	Another	recent	review	by	Sage	et	al	(2013)	compared	the	two	techniques	and	found	that	there	is	a	significant	difference	found	in	pain	and	abduction	six	weeks	following	the	injection.	However,	these	differences	were	deemed	to	not	be	useful	clinically.	This	review	also	suggested	the	cost-effectiveness	of	both	types	of	injections	should	be	considered	in	future	studies.			
Accuracy	While	physicians	have	begun	utilizing	US-guided	cortisone	injections	in	an	attempt	to	improve	accuracy	of	the	injection,	the	evidence	supporting	that	improved	accuracy	results	in	improved	efficacy	remains	unclear.	In	a	study	by	Eustace	et	al	(1997)	the	effect	of	accuracy	of	corticosteroid	injections	administered	to	the	shoulder	on	clinical	outcomes	was	examined.	Only	29%	of	the	14	subacromial	injections	were	found	to	be	accurate,	while	42%	of	the	24	GH	joint	injections	were	deemed	accurate.	Significant	differences	were	found	in	relation	to	outcome	between	the	accurate	and	inaccurate	groups.	Given	this,	it	was	concluded	that	accuracy	of	a	cortisone	injection	in	the	shoulder	could	significantly	affect	the	clinical	outcome.		
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However,	a	more	recent	review	by	Hegedus	et	al	(2010)	that	evaluated	improvement	in	shoulder	pain	and	function	between	patients	who	received	accurate	and	inaccurate	corticosteroid	injections	found	no	significant	differences	in	outcomes	between	the	groups.	Thus,	results	suggested	that	accuracy	might	not	influence	the	efficacy	of	the	injection.	Given	this	conflicting	evidence,	further	research	is	required	to	establish	whether	or	not	accuracy	of	a	corticosteroid	injection	in	the	shoulder	impacts	its	efficacy.				
Alternative	Treatment	Modalities	While	NSAIDs,	physical	therapy,	and	corticosteroid	injections	represent	some	of	the	common	treatment	options	for	patients	with	adhesive	capsulitis,	there	are	also	a	few	unconventional	treatment	methods	that	have	been	evaluated.		Two	examples	of	these	alternative	modalities	include	acupuncture	and	PRP	therapy.		A	Cochrane	review	by	Green	et	al	(2005)	on	acupuncture	for	shoulder	pain	established	that	it	was	unclear	whether	acupuncture	alone	is	an	effective	measure	for	treating	shoulder	pain,	although	improvement	may	be	seen	in	pain	and	function	at	2-4	weeks.	However,	a	study	conducted	by	Ma	et	al	(2006)	utilized	an	unconventional	combination	of	therapies	involving	the	integration	of	traditional	Chinese	(acupuncture)	and	Western	medicine	(physical	therapy)	for	adhesive	capsulitis.	Results	demonstrated	that	the	remedies	together	resulted	in	better	outcomes	than	when	either	is	used	alone.	Every	participant	showed	an	increase	in	quality	of	life,	where	pain	was	managed	with	acupuncture	while	range	of	motion	
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was	addressed	with	PT.	These	findings	suggest	that	the	integration	of	physical	therapy	and	acupuncture	was	effective	for	adhesive	capsulitis.		Furthermore,	the	combination	of	Chinese	and	Western	medicine	in	management	of	this	debilitating	condition	should	be	considered	and	further	researched.		A	recent	experimental	treatment	for	this	condition	consisted	of	a	case	study	for	platelet-rich	plasma	(PRP)	therapy	(Aslani	et	al.,	2016).	Prior	to	this	study,	there	had	been	no	clinical	evidence	that	PRP	therapy	was	effective	in	treating	adhesive	capsulitis.	The	treatment	was	performed	on	a	45	year-old	male	who	received	two	consecutive	PRP	injections	at	the	seventh	and	eighth	months	after	initially	developing	his	symptoms.	The	patient	reported	significant	reduction	in	pain,	two-fold	improvement	in	his	ROM,	and	over	70%	improvement	in	function	following	the	injections.	This	case	study	provides	evidence	for	PRP	therapy	to	be	further	researched	as	a	potential	treatment	method	for	frozen	shoulder.	Specifically,	PRP	therapy	would	need	to	assessed	in	future	randomized	trials	where	its	effectiveness	can	be	compared	to	that	of	corticosteroid	injections	and	physiotherapy.		
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	 	 SPECIFIC	AIMS	
	1. Comprehensive	review	of	literature	to	further	elaborate	upon	the	various	treatment	modalities	for	adhesive	capsulitis.	2. Evaluate	the	effectiveness	of	both	landmark	and	US-guided	cortisone	injections	in	terms	of	VAS	scores,	SANE	scores,	and	ROM	outcomes	for	adhesive	capsulitis.	3. Compare	pain	relief	and	self-reported	function	results	of	landmark	versus	US-guided	corticosteroid	injections	for	adhesive	capsulitis.	4. Compare	the	improvement	in	shoulder	ROM	between	landmark	and	US-guided	corticosteroid	injections	for	adhesive	capsulitis.	
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METHODS	
Participants	and	Eligibility	The	BIDMC	Committee	on	Clinical	Investigations	approved	this	study	(IRB	protocol	#:	2015P000157).	This	preliminary	report	is	of	a	prospective	study	that	was	conducted	at	BIDMC	from	August	2015	through	March	of	2017.	The	purpose	of	this	study	was	to	compare	two	methods	of	intra-articular	corticosteroid	injection,	landmark	and	US	guided,	in	the	treatment	of	adhesive	capsulitis	of	the	shoulder.		Inclusion	criteria	for	the	study	were	that	patients	needed	to	be	of	the	age	18	or	older,	have	adhesive	capsulitis	of	the	shoulder	confirmed	by	the	physician,	self-reported	pain	and/or	stiffness	in	the	shoulder	for	more	than	three	months,	and	willingness	to	continue	care	at	BIDMC	Department	of	Orthopaedics	through	planned	study	follow-up.		Exclusion	criteria	for	the	study	were	previous	history	of	an	intra-articular	shoulder	corticosteroid	injection,	previous	diagnosis	of	calcific	tendonitis	or	evidence	of	calcific	tendonitis	on	X-ray,	previous	diagnosis	of	cervical	radiculopathy	or	the	presence	of	one	or	more	of	the	following	signs	on	physical	exam	(Spurling’s	sign,	neck	pain,	radiating	arm	pain	or	numbness,	sensory	defects,	and	motor	dysfunction	in	the	neck	and	upper	extremities),	radiographic	evidence	of	Os	Acromiale,	currently	receiving	protease	inhibitors,	or	suspected	full	thickness	RTC	tear,	as	identified	by	evidence	of	a	full	thickness	tear	on	MRI	or	US,	weakness	of	arm	elevation,	a	positive	“drop	arm	sign”,	or	a	high-riding	humerus	visible	on	the	shoulder	X-ray.		
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From	August	2015	through	March	of	2017	there	were	a	total	of	22	patients	that	were	seen	at	BIDMC	with	a	diagnosis	of	adhesive	capsulitis	that	were	screened	for	eligibility.	Of	the	22	patients	that	were	screened,	only	one	was	omitted	due	to	exclusion	criteria	of	having	a	history	of	an	intra-articular	shoulder	corticosteroid	injection.	The	remaining	21	patients	were	included	in	the	study	after	signing	informed	consents	and	then	subsequently	being	randomized.			
Randomization	This	prospective	study	randomized	patients	into	two	different	groups.	Participants	were	randomized	into	Groups	1	and	2	through	the	use	of	the	random	number	generator	on	“random.org.”	On	this	website	the	minimum	was	set	to	1	and	the	maximum	was	set	to	two,	which	ensured	that	each	participant	had	an	equal	chance	to	be	allocated	to	either	group.	Patients	that	were	assigned	to	Group	1	received	a	blind	or	landmark	corticosteroid	injection	into	the	GH	joint	of	the	affected	shoulder.	Patients	allocated	to	Group	2	were	administered	a	corticosteroid	injection	under	US	guidance	by	a	radiologist.	All	participants	in	the	study,	regardless	of	which	group	they	were	assigned	to,	were	subjected	to	the	same	rehabilitation	protocol	that	entailed	formal	physical	therapy	for	a	total	of	six	weeks,	two	times	a	week.	Physical	therapy	consisted	of	shoulder	range	of	motion	and	strengthening	exercises,	more	specifically	those	focused	on	the	RTC	and	periscapular	region	(trapezius	and	serratus	anterior).	Posterior	capsular	stretching	was	also	utilized.	Additionally,	the	therapists	instructed	the	patients	to	supplement	physical	therapy	with	a	home	
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exercise	program	that	they	would	continue	to	implement	following	the	termination	therapy.			Four	patients	were	lost	to	follow-up	in	Group	1	because	they	could	not	attend	the	required	visits.	Two	patients	were	lost	in	Group	2,	one	due	to	inability	to	attend	a	scheduled	visit	and	the	other	due	to	an	incorrect	procedure	protocol	(patient	received	corticosteroid	injection	under	fluoroscopy	instead	of	US	guidance).	A	representative	Consilidated	Standards	of	Reporting	Trials	(CONSORT)	flow	diagram	for	the	study	is	depicted	below	(Figure	2).	
Figure	2.	Flow	diagram	of	patients	recruitment	based	on	CONSORT	criteria.	
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Intervention	 	Subsequent	to	randomization,	patients	in	Group	1	received	a	landmark	GH	joint	corticosteroid	injection	into	the	effected	shoulder.	The	landmark	injections	were	administered	in	clinic	by	one	of	the	two	orthopedic	surgeons	involved	in	the	study.	Risks	and	benefits	of	the	injection	were	discussed.	After	informed	consent	the	affected	shoulder	was	prepped	sterilely.	First,	a	dose	of	3	cc	of	1%	Lidocaine	was	administered	to	the	shoulder	to	achieve	local	anesthesia.	Following	this,	the	intra-articular	corticosteroid	injection	consisting	of	a	mixture	of	4	mL	of	10	mg/mL	Triamcinolone	Acetonide	and	1	mL	of	0.25%	Bupivacaine	was	administered.	The	injection	site	(GH	joint)	was	determined	through	the	palpation	of	anatomical	landmarks:	medial	to	the	humeral	head	and	1	cm	lateral	to	the	coracoid	process	of	the	effected	shoulder.	The	injection	was	administered	through	an	anterior	approach	with	a	22-gauge	spinal	needle	directed	posteriorly	with	a	slightly	superolateral	angle	(Figure	3).		Patients	that	were	allocated	to	Group	2	had	to	set	up	a	separate	visit	with	the	Radiology	department	of	BIDMC	to	receive	the	US-guided	injection.	These	injections	were	administered	by	one	of	the	two	radiologists	that	were	involved	in	the	study.	After	risks,	benefits,	and	informed	consent	an	US	was	performed	and	the	injection	site	was	located.	The	affected	shoulder	was	then	prepped	sterilely	and	infiltrated	with	3	cc	of	1%	Lidocaine	to	achieve	local	anesthesia.	While	under	US	visualization,	a	22-gauge	needle	was	advanced	to	the	GH	joint	and	an	injection	of	40	mg	of	10	
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mg/mL	Triamcinolone	Acetonide	and	1	mL	of	0.25%	Bupivacaine	was	administered.	After	the	injection	the	patient	was	assessed	for	any	immediate	complications	and	then	left	the	department	in	stable	condition.	There	were	no	adverse	reactions	documented	in	any	of	the	participants	from	either	group	subsequent	to	receiving	the	cortisone	injection.		 .		
	
	
	
	
	
	
	
	
	
Figure	3.	Injection	technique	used	to	administer	landmark	injections	(Group	
1).	
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Figure	4.	US-guided	injection	(Group	2).	
	
Outcome	Measurements	Clinical	and	functional	guidelines	were	documented	at	baseline	and	at	follow-ups	at	6	and	12	weeks	post-injection.	Outcome	measures	included	VAS	for	pain,	which	is	measured	on	a	0-10	scale,	with	10	being	the	most	severe	pain.	Another	outcome	measure	used	was	the	SANE	score	for	self-reported	function,	which	is	measured	on	a	0-100	scale	with	100	representing	optimal	shoulder	function.	Finally,	passive	range	of	motion	was	measured	with	the	patient	in	the	upright	position,	including	forward	flexion,	external	rotation,	and	abduction.	
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Statistical	Analysis		 The	six	patients	in	Group	1	and	the	two	patients	in	Group	2	that	were	missing	data	due	to	loss	to	follow-up	were	included	in	this	analysis	given	the	limited	number	of	participants	for	this	preliminary	report.	However,	the	patient	that	received	the	incorrect	injection	protocol	was	not	included	in	the	study.	Therefore,	the	analysis	was	performed	on	11	patients	in	the	landmark	corticosteroid	injection	group	and	9	patients	in	the	US-guided	corticosteroid	injection	group.	This	statistical	analysis	was	performed	using	SPSS	version	22.0	software.	Univariate	descriptive	statistics	were	also	used	for	demographic	information,	including	race,	ethnicity,	gender,	age,	and	affected	shoulder.	Median	and	range	were	determined	for	all	of	the	outcome	measures	(VAS,	SANE,	and	ROM:	forward	flexion,	external	rotation,	and	abduction).	Comparisons	between	groups	at	baseline	and	at	each	follow-up	(6	and	12	weeks)	for	all	outcome	measures	were	performed	with	Mann-Whitney	U	tests.	Comparisons	within	each	group	between	baseline	and	each	follow-up	period	for	all	outcome	measures	were	performed	using	the	Wilcoxon	signed	rank	test.		A	P	value	of	<.05	was	considered	statistically	significant.	
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RESULTS	The	20	patients	included	in	this	preliminary	report	consisted	of	50%	(n=10)	males	and	50%	females	(n=10).	The	ages	of	the	study	population	ranged	from	42	to	73	years	with	an	average	age	of	54	years.	Twelve	of	the	subjects	affected	shoulder	was	the	right	(60%)	and	eight	of	the	subjects	affected	shoulder	was	the	left	(40%).	With	respect	to	ethnicity,	only	10%	of	the	study	population	identified	as	Hispanic.	In	regards	to	race,	85%	of	the	participants	identified	as	White,	while	the	other	15%	of	the	participants	identified	as	Black/African	American.		
Changes	in	VAS	Scores		 The	mean	baseline	VAS	scores	were	found	to	be	similar	between	the	two	treatment	groups.	There	was	significant	improvement	seen	in	terms	of	pain	in	both	groups.	The	improvement	in	VAS	scores	in	the	two	groups	was	maintained	at	the	6	week	and	12	week	assessments	(Table	2).	Following	the	completion	of	the	12	week	treatment,	average	VAS	scores	decreased	by	4	in	the	US-guided	group	and	approximately	4.75	in	the	landmark	group.	There	was	no	significant	difference	seen	in	reduction	of	pain	between	the	US-guided	or	landmark	groups	at	either	time	point	(Figure	5).			
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Table	2.	Statistics	of	the	Differences	in	VAS	Scores	by	Time	and	Treatment	
Group	
aValues	demonstrate	mean	VAS	scores	with	ranges	in	the	parentheses.	bP	values	compare	mean	VAS	score	differences	between	baseline	and	follow-up	periods	within	each	group.	cP	values	compare	mean	VAS	score	differences	between	the	landmark	and	US-guided	groups	at	each	time	period.	
	
	
Figure	5.	Comparison	of	Changes	in	Mean	VAS	Scores	Between	Treatment	
Groups	
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Changes	in	SANE	Scores	 		 According	to	the	analysis,	mean	baseline	SANE	scores	were	similar	between	the	two	treatment	groups	(US-guided/landmark:	47.2/34.1,	P	=	.157).	There	was	significant	improvement	in	SANE	scores	for	the	landmark	and	US-guided	groups	at	both	the	6	week	and	12	week	time	periods	(Table	3).	However,	when	comparing	the	two	treatment	groups	there	were	no	significant	differences	seen	at	any	of	the	time	periods.	Overall,	the	average	SANE	scores	improved	by	56.0	in	the	landmark	group	and	35.4	in	the	US-guided	group	by	the	end	of	the	treatment.	Although	not	statistically	significant,	mean	SANE	scores	at	the	end	of	the	12	week	follow-up	period	were	90.1	in	the	landmark	group	and	82.6	in	the	US-guided	group	(Figure	6).			
	
Table	3.	Statistics	of	the	Differences	in	SANE	Scores	by	Time	and	Treatment	
Group	
aValues	demonstrate	mean	SANE	scores	with	ranges	in	the	parentheses.	bP	values	compare	mean	SANE	score	differences	between	baseline	and	follow-up	periods	within	each	group.	cP	values	compare	mean	SANE	score	differences	between	the	landmark	and	US-guided	groups	at	each	time	period.			 	
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Figure	6.	Comparison	of	Changes	in	Mean	SANE	Scores	Between	Treatment	
Groups	
	
	
Changes	in	Shoulder	ROM			 Based	on	analysis,	there	were	no	significant	differences	seen	at	baseline	between	the	two	groups	in	any	of	the	ROM	categories	(forward	flexion,	external	rotation,	or	abduction).	With	respect	to	forward	flexion,	there	was	significant	improvement	seen	in	the	US-guided	group	and	landmark	group	at	both	follow-up	visits.	There	were	no	significant	differences	seen	between	the	groups	for	forward	flexion	at	any	time	period.	In	regards	to	mean	external	rotation	outcomes,	both	groups	saw	significant	improvement	throughout	the	length	of	the	study.	Again,	there	were	no	significant	differences	seen	in	mean	external	rotation	outcomes	between	the	groups	throughout	the	treatment.	With	respect	to	mean	abduction	
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outcomes,	both	the	landmark	and	US-guided	groups	significantly	improved	throughout	the	12	week	treatment	period.	There	was	a	significant	difference	seen	in	mean	abduction	outcomes	between	the	two	treatment	groups	at	the	6	week	follow-up	(P	=	.004),	in	favor	of	the	US-guided	group.	However,	the	difference	between	the	groups	lost	significance	at	the	12	week	follow-up.	
	
Table	4.	Statistics	of	the	Differences	in	ROM	Outcomes	by	Time	and	Treatment	
Group	
aValues	demonstrate	mean	ROM	scores	with	ranges	in	the	parentheses.	bP	values	compare	mean	ROM	differences	between	baseline	and	follow-up	periods	within	each	group.	cP	values	compare	mean	ROM	differences	between	the	landmark	and	US-guided	groups	at	each	time	period.		 	
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DISCUSSION		 The	principal	finding	of	this	preliminary	report	is	that	US-guided	intra-articular	cortisone	injections	showed	no	significant	differences	in	pain	reduction,	self-reported	function,	or	shoulder	ROM	outcomes	than	landmark	injections	for	adhesive	capsulitis.	US-guided	injections	were	only	found	to	significantly	improve	mean	abduction	outcomes	compared	to	landmark	injections	at	6	weeks	post-injection	(P	=	.004).	Of	note,	there	were	significant	improvements	seen	in	all	outcome	measures,	regardless	of	group	assignment,	at	both	the	6	week	and	12	week	assessments.	The	improvements	noted	at	6	weeks	were	maintained	at	the	12	week	time	period	for	all	outcome	measures	in	both	groups.		 Studies	by	Carette	et	al	(2003)	and	Ryans	et	al	(2005)	have	found	that	combining	a	corticosteroid	injection	with	PT	is	more	beneficial	than	an	injection	or	PT	alone,	in	terms	of	both	pain	and	mobility.	This	research	supports	the	inclusion	of	a	physical	therapy	regimen	for	all	participants	subsequent	to	receiving	the	injections	in	this	study.	It	is	believed	the	cortisone	injection	helps	patients	progress	through	the	stages	of	rehabilitation	faster	in	addition	to	alleviating	pain.	Prior	to	this	study,	the	only	two	other	prospective	studies	that	have	compared	US-guided	and	landmark	injections	for	adhesive	capsulitis	found	significant	differences	in	terms	of	pain	and	shoulder	motion.	However,	neither	of	these	studies	examined	the	impact	of	these	injection	techniques	alone	for	adhesive	capsulitis.		The	study	by	Lee	et	al	(2009)	found	that	US-guided	injections	provided	greater	pain	improvement	and	shoulder	mobility	two	weeks	subsequent	to	the	
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injection,	yet	followed	the	cortisone	injections	with	subsequent	hyaluronate	injections.	The	other	study	found	that	the	US-guided	injections	delivered	better	ROM	and	pain	outcomes	than	landmark	injections	at	6	weeks	post-injection	(Ucuncu	2009).	Yet,	it	did	not	observe	adhesive	capsulitis	alone	and	instead	assessed	results	for	other	shoulder	pathologies	as	well.	The	results	of	these	two	studies	conflict	with	the	findings	of	our	study,	in	which	there	were	no	significant	differences	in	any	of	the	outcome	measures	between	the	two	treatment	groups.	To	our	knowledge	this	is	the	first	study	that	has	examined	the	effects	of	landmark	and	US-guided	injections	alone	for	adhesive	capsulitis.		A	Cochrane	review	by	Bloom	et	al	(2012)	supported	the	results	found	in	our	study.	This	review	showed	that	there	were	no	significant	differences	found	between	US-guided	and	blind	cortisone	injections	in	terms	of	reduction	of	pain	or	improvement	in	shoulder	ROM	(Bloom	2012).	Another	recent	review	by	Sage	et	al	(2013)	demonstrated	that	there	is	a	significant	difference	found	in	pain	and	abduction	six	weeks	following	the	injection.	In	comparison	to	our	study,	no	significant	difference	was	found	between	the	two	groups	in	terms	of	VAS	scores	but	US-guided	significantly	improved	abduction	outcomes	compared	to	landmark	at	the	6	week	follow-up	period.	Research	surrounding	this	topic	remains	ambiguous	and	there	is	clearly	a	necessity	of	further	investigation	in	the	future.	The	completion	of	our	study	in	the	upcoming	months	will	provide	a	stronger	analysis	between	US-guided	and	landmark	injections	given	that	there	will	be	a	larger	study	population	and	more	concrete	data.		
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Given	the	findings	of	this	preliminary	report	and	the	current	research	on	the	effectiveness	of	subacromial	injections	for	frozen	shoulder	(Oh	2011,	Shin	2013,	Kim	2015),	implications	for	a	future	randomized	controlled	trial	comparing	the	efficacies	of	US-guided,	landmark,	and	subacromial	corticosteroid	injections	for	adhesive	capsulitis	should	be	considered.				
Limitations	of	This	Study	 	Limitations	of	this	preliminary	report	include	a	small	patient	population	(n=20),	in	which	several	of	the	patients	missed	at	least	one	follow-up	appointment.	Given	the	limited	study	population,	those	who	were	lost	to	follow-up	were	still	included	in	the	statistical	analysis.	This	can	have	implications	in	the	strength	and	validity	of	the	analysis,	which	in	turn	can	alter	the	conclusions	that	can	be	made.		Another	limitation	was	the	substandard	methodological	characteristics	used.	While	exclusion	criteria	included	MRI	evidence	of	a	full-thickness	RTC	tear,	only	30%	(n=6)	of	the	participants	in	the	study	underwent	an	MRI.	A	relatively	recent	study	evaluated	patients	considered	to	be	in	the	“frozen”	stage	of	adhesive	capsulitis,	in	which	approximately	one	third	had	MRI	findings	of	RTC	tears	(Yoo	2009).		Additionally,	while	duration	of	pain	for	more	than	three	months	was	an	inclusion	criterion,	the	study	did	not	specify	the	stage	of	disease	of	the	participants,	which	has	been	identified	as	a	predictor	of	prognosis	in	conservative	treatment	(Rill	2011).	Finally,	the	short-term	follow-ups	could	be	considered	as	another	limitation.	However,	several	of	the	previously	mentioned	studies	examining	the	effects	of	
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cortisone	injections	for	adhesive	capsulitis	utilized	similar	time	formats,	so	it	was	felt	that	the	12	week	treatment	period	was	appropriate	for	this	study.		
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